Hyerose Pharma Private Limited, a active private limited company, was established on 18 July 2018 in Chenganuur, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909KL2018PTC054088. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Deepak Gopinatha Panikker (Director), Gowrinandana Deepak (Director). Past directors included Deepak Devinandana, Suseela. It holds ₹0.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2/416 Thiruvanvandoor, Chenganuur, Kerala, 689109.
U51909KL2018PTC054088
054088
18 July 2018
₹1.00 M
₹0.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Hyerose Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Gopinatha Panikker | Director | 18 Jul 2018 | Current |
| Gowrinandana Deepak | Director | 16 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jan 2025 | Past |
| Pramod Abcsdd | Director | 05 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hyerose Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 129.4% increase. The company also saw a substantial improvement in profitability, with a 96.49% increase in profit. The company's net worth dipped by a decrease of 2.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Hyerose Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹896,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2020 | Others | ₹0.15 M | Open |
| 03 Nov 2018 | Others | ₹0.75 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hyerose Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hyerose Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyerose Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gowrinandana Deepak was appointed as a Director was appointed as a Director on 16 Jan 2025 & has been associated with this company since 11 months . was documented.
Progress on Hyerose Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Hyerose Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
The activity A charge with Others amounted to Rs. 0.15 M with Charge ID 100343144 was registered on 10 Jun 2020. was completed.
A charge with Others amounted to Rs. 0.75 M with Charge ID 100218313 was registered on 03 Nov 2018. was recorded as a recent event.
The activity Deepak Gopinatha Panikker was appointed as a Director was appointed as a Director on 18 Jul 2018 & has been associated with this company since 7 years 5 months . was completed.
The CIN of Hyerose Pharma Private Limited is U51909KL2018PTC054088.
Hyerose Pharma Private Limited is headquartered at 2/416 Thiruvanvandoor, Chenganuur, Kerala, 689109.
Hyerose Pharma Private Limited was incorporated on 18 July 2018.
The current directors of Hyerose Pharma Private Limited are
The primary industry of Hyerose Pharma Private Limited is Pharma.
Hyerose Pharma Private Limited is unlisted.
The authorized capital of Hyerose Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX